BIOTRICITY INC. - Common Stock, par value $0.001 per share (BTCY)
CUSIP: 09074H203
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 30,666,263
- Total 13F shares
- 481,039
- Share change
- +134,278
- Total reported value
- $431,539
- Price per share
- $0.90
- Number of holders
- 19
- Value change
- +$120,741
- Number of buys
- 9
- Number of sells
- 3
Quarterly Holders Quick Answers
What is CUSIP 09074H203?
CUSIP 09074H203 identifies BTCY - BIOTRICITY INC. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09074H203:
Top shareholders of BTCY - BIOTRICITY INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Norman M. Betts |
3/4/5
|
Director |
—
class O/S missing
|
375,598
|
$1,145,574 | — | 29 Nov 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.33%
|
102,576
|
$151,812 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.21%
|
64,074
|
$94,847 | — | 31 Mar 2024 | |
| Advisor Resource Council |
13F
|
Company |
0.26%
|
79,070
|
$90,931 | — | 31 Mar 2024 | |
| Strengthening Families & Communities, LLC |
13F
|
Company |
0.16%
|
48,263
|
$71,000 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.07%
|
22,548
|
$33,371 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.04%
|
13,375
|
$19,795 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
12,002
|
$17,763 | — | 31 Mar 2024 | |
| TD Waterhouse Canada Inc. |
13F
|
Company |
0.03%
|
8,000
|
$10,240 | — | 31 Mar 2024 | |
| Cedar Mountain Advisors, LLC |
13F
|
Company |
0.01%
|
2,501
|
$3,701 | — | 31 Mar 2024 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.01%
|
1,620
|
$2,398 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,524
|
$2,256 | — | 31 Mar 2024 | |
| Princeton Global Asset Management LLC |
13F
|
Company |
—
class O/S missing
|
834
|
$1,234 | — | 31 Mar 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
501
|
$1,000 | — | 31 Mar 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
210
|
$310 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
71
|
$105 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
57
|
$84 | — | 31 Mar 2024 | |
| EverSource Wealth Advisors, LLC |
13F
|
Company |
—
class O/S missing
|
23
|
$31 | — | 31 Mar 2024 | |
| Waqaas Al-Siddiq |
3/4/5
|
President, CEO and Chairman, Director |
—
class O/S missing
|
4,899,984
|
— | — | 12 Mar 2023 | |
| John Ayanoglou |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
1,328,488
|
— | — | 26 Oct 2017 | |
| David A. Rosa |
3/4/5
|
Director |
—
class O/S missing
|
474,683
|
— | — | 12 Mar 2023 |
Institutional Holders of BIOTRICITY INC. - Common Stock, par value $0.001 per share (BTCY) as of Q2 2024
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.